|
|
| March 24, 2012: Dr. James McKenney and Dr. Nihar R. Desai discuss: A Randomized, Double Blind, Placebo-controlled Trial of the Safety an |
Dr. James McKenney and Dr. Nihar R. Desai discuss: A Randomized, Double Blind,
Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein
Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with
Primary Hypercholesterolemia (NCT: 01288443)
Received research funding from Regeneron and/or Sanofi
[ Download video ] |
|
No comments have been submitted
|